Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 96Leukemia 90Myelodysplastic Syndromes 83Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma, Non-Hodgkin 62Lymphoma 60Multiple Myeloma 53Hodgkin Disease 48Leukemia, Lymphocytic, Chronic, B-Cell 46Myeloproliferative Disorders 41Leukemia, Myeloid, Chronic-Phase 41Leukemia, Myeloid, Accelerated Phase 37Congenital Abnormalities 37Lymphoma, Large B-Cell, Diffuse 35Neoplasms, Plasma Cell 34Lymphoma, Follicular 34Leukemia, Myelomonocytic, Chronic 34Burkitt Lymphoma 33Anemia, Refractory, with Excess of Blasts 32Lymphoma, Mantle-Cell 31Lymphoma, B-Cell, Marginal Zone 29Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Lymphoma, Large-Cell, Immunoblastic 28Blast Crisis 26Myelodysplastic-Myeloproliferative Diseases 25Recurrence 24Primary Myelofibrosis 24Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24Hematologic Neoplasms 24Dendritic Cell Sarcoma, Interdigitating 22

Interventions

fludarabine phosphate 5fludarabine 3Busulfan 3Antilymphocyte Serum 3Whole-Body Irradiation 2Mycophenolic Acid 2Cyclophosphamide 2Clofarabine 2Alemtuzumab 2treosulfan 1thymoglobulin 1eltrombopag 1X-Rays 1Thiotepa 1Therapeutics 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Emapalumab 1Cyclosporins 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Bone Marrow Failure Disorders × Busulfan × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡